Key result
Surgical TAVI explantation carries ~16% 30-day mortality regardless of explantation delay.
Why the study?
Surgical explantation of transcatheter aortic valves is increasingly required as TAVI expands to younger and lower-risk patients, but contemporary evidence on outcomes, timing, and valve type remains limited.
Does the timing of surgical explantation after index TAVI affect 30-day mortality in patients undergoing TAV-explant?
Population
62 patients undergoing surgical TAV-explant
Comparison
Interval between index TAVI and explant (<1 month vs 1-12 months vs >12 months) and valve type
Design
Multicenter retrospective study
Follow-up
30 days
Authors
Loading...
Provides no basis for timing explant delay to improve 30-day mortality; leaves open optimal strategy pending randomized evaluation.
Observational (n=62)
Yes
Does the timing of surgical explantation after index TAVI affect 30-day mortality in patients undergoing TAV-explant?
p-value: p=0.816
Surgical explantation of transcatheter aortic valves is associated with a high 30-day mortality of 16.1%, which is not significantly influenced by the timing of explantation or the type of initial valve.
Eid et al. (2026) conducted an observational in Transcatheter aortic valve explantation (n=62). Surgical TAV-explantation vs. Different timing intervals (< 1 month, 1-12 months, > 12 months) was evaluated on 30-day mortality (p=0.816). Surgical transcatheter aortic valve explantation had an overall 30-day mortality of 16.1%, which did not differ significantly according to the delay of explantation (p=0.816).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: